tiprankstipranks
Trending News
More News >
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market

VistaGen Therapeutics (VTGN) Balance Sheet

Compare
1,181 Followers

VistaGen Therapeutics Balance Sheet

VistaGen Therapeutics's total assets for Q2 2026 were $80.93M, an increase of 17.42% from the previous quarter. VTGN total liabilities were $14.59M for the fiscal quarter, a 19.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 84.34M$ 123.65M$ 21.09M$ 74.64M$ 108.28M
Total Liabilities
$ 13.95M$ 9.37M$ 9.01M$ 9.93M$ 16.30M
Total Equity Gross Minority
$ 70.39M$ 114.29M$ 12.08M$ 64.72M$ 91.98M
Other Metrics
Currency in USD

VistaGen Therapeutics Debt to Assets